- July 14, 2026
- 2:31 pm
- Israel
On July 14, 2026, the Chief Rabbi of Kyiv and Ukraine, Moshe Reuven Asman, reported from Herzliya, Israel, that CarboFix Orthopedics is establishing a branch in Ukraine and preparing to supply modern orthopedic implants to Ukrainian hospitals.
These are structures for treating complex fractures of the upper and lower limbs, spinal injuries, and oncological bone lesions. The main feature of the technology is the use of a carbon composite material, which significantly interferes less with X-ray, CT, and MRI examinations than traditional massive metal structures.
In a written message, Moshe Asman noted that the CarboFix Orthopedics branch in Ukraine is already in the process of opening. In the published video, he was even more specific: according to the rabbi, the branch is already being established, and the implants themselves should soon arrive in Ukraine.
“There is already a branch in Ukraine. I think that many people — military personnel, the wounded, and civilians — will be able to benefit from these unique prostheses. They will soon arrive in Ukraine and help people heal,” said Moshe Asman.
However, it is technically more correct to call CarboFix products not prostheses, but orthopedic implants. They do not replace a lost limb like a regular prosthesis but are surgically installed inside the body to fix bones, stabilize the spine, and treat fractures.
NANews — Israel News | Nikk.Agency views this initiative as another practical example of Israeli-Ukrainian cooperation, capable of directly influencing the treatment of people. It is not only about the entry of an Israeli medical company into the Ukrainian market but also about the possible transfer of technologies to Ukraine, especially necessary to help wounded military personnel, affected civilians, and patients with complex injuries or oncological diseases.
Moshe Asman’s visit to Herzliya
The video was recorded in Herzliya — a city in central Israel, where the Israeli office of CarboFix Orthopedics is located. The official address of the company is 11 Ha’Hoshlim Street, Herzliya 4672411, Israel. This same address is listed in the documents of the U.S. Food and Drug Administration — FDA.
At the beginning of the video, Moshe Asman emphasized that he arrived at a company with unique technology for producing orthopedic products for the spine and limbs.
According to the rabbi, CarboFix products are exported to many countries around the world. He characterized the company’s carbon technology as more modern compared to traditional titanium structures.
The conversation included a company representative named Alexander, from Ukraine.
Alexander explained that the company produces products for treating various types of fractures — injuries to the spine, arms, legs, and almost all major bones.
The footage showed elements of the spinal system, including screws that are installed in the spine to fix and align damaged or unstable segments.
“The most important thing about this technology is our carbon products. They are very well accepted by the body, do not create reflections, do not interfere with further intermediate checks, and are very light,” explained the company representative.
Most likely, the absence of “reflection” referred to the reduction of radiological and tomographic artifacts. Metal structures can obscure part of the bone on an X-ray and create distortions during CT and MRI. CarboFix carbon-polymer implants are radiolucent and provide minimal interference during diagnostics.
Branch and first deliveries
Asman’s written message and his words in the video differ somewhat in wording.
The text states that the branch “is already opening”. In the video, the rabbi says that the branch in Ukraine “already exists”, then adds that the implants will soon arrive in the country.
Most likely, this is a transitional stage: a Ukrainian representative or distributor has already been identified, but legal, registration, and logistical procedures are not yet complete. This would explain why Moshe Asman speaks of an existing branch, while CarboFix’s official contacts do not yet include a separate Ukrainian office.
At the time of publication, the company has not disclosed:
- the legal name of the Ukrainian branch or distributor;
- the name of its head;
- the address of the office or warehouse;
- the start date of regular deliveries;
- the list of modern implants registered for Ukraine;
- the names of hospitals that will receive the products first;
- the estimated cost of operations;
- the conditions for providing implants to wounded military personnel and civilians.
Therefore, it is premature to assert that a full-fledged CarboFix office in Ukraine has officially started operations. However, Asman’s video statement indicates that preparations have moved beyond preliminary interest and are already associated with expected product deliveries.
What CarboFix Orthopedics produces
CarboFix Orthopedics is an Israeli medical technology company specializing in the development of orthopedic implants made from polymer materials reinforced with continuous carbon fibers.
The company’s official website lists two main product groups.
Piccolo Composite — plates and intramedullary nails for fixing fractures of the humerus, femur, tibia, radius, and fibula. The line also includes structures for the ankle joint and complex fractures of the lower limbs.
CarboClear — systems for spinal surgery. They include transpedicular and cervical screws, rods, intervertebral implants, vertebral body replacement systems, and structures for treating patients with spinal tumor lesions.
Different sources provide different dates for the creation of CarboFix. The European distributor Adyton names 2003, PitchBook — 2009, and the Israeli Startup Nation Central database indicates January 2011. The latter also provides the Israeli company’s registration number — 514562628. The discrepancies are likely related to the stages of technology development, business establishment, and subsequent registration of the current legal entity.
Today, CarboFix operates through its own divisions and international partners. In addition to Israel, the company indicates presence in the USA and China, as well as cooperation with European representatives and distributors. The Ukrainian office has not yet appeared in the public contact list.
Not just “carbon,” but a complex medical composite
The phrase “carbon implants” conveys the essence of the technology but is simplified.
The material is called CFR-PEEK — carbon-fiber-reinforced polyetheretherketone. This is a medical polymer PEEK, reinforced with continuous carbon fibers.
The fibers are arranged longitudinally, diagonally, and spirally, forming a strong structure. Thanks to this, the material can withstand the loads necessary for fixing large bones and the spine.
The company claims that its plates and nails are radiolucent. This allows doctors to better see the fracture line, the position of bone fragments, and the formation of callus during surgery and subsequent examinations. During CT and MRI, the material creates minimal artifacts, facilitating the assessment of bones, soft tissues, and the area around the implant.
This is especially important for patients with oncological diseases. After removing a bone or vertebra tumor, a person needs to regularly undergo control studies. A massive metal structure can partially obscure the area under study, while a radiolucent implant facilitates monitoring for possible recurrence.
Carbon-polymer structures can also simplify the planning of radiation therapy. The manufacturer indicates that the material does not create the characteristic metal backscatter and has less impact on radiation passage.
However, not all CarboFix systems are completely devoid of metal elements.
FDA documentation indicates that hybrid spinal screws are made from CFR-PEEK but may have a titanium head, a thin titanium shell around the threaded part, and tantalum markers. Separate fixing elements and rods can also be made from titanium.
Therefore, the technological advantage lies not in the complete abandonment of metal but in replacing the massive metal base with a radiolucent carbon-polymer material.
More than fifteen years of medical system registration
CarboFix developments are not experimental samples created specifically for the Ukrainian market. Different company systems have undergone the American FDA 510(k) procedure for more than fifteen years.
On May 3, 2011, a decision was made on the Piccolo Composite intramedullary nail system for the femur and tibia.
On July 28, 2015 — on the proximal femur fixation system.
On July 18, 2018 — on the CarboClear transpedicular system for the thoracic, lumbar, and sacral spine.
On October 11, 2019 — on the CarboClear VBR system, designed to replace a vertebral body damaged or destroyed by a tumor.
On March 2, 2020 — on the CarboClear Lumbar Cage intervertebral system.
On April 25, 2024, the FDA made a decision on the hybrid CarboClear transpedicular system, including navigation tools and screw options that can be used with bone cement.
On March 16, 2026, less than four months before Moshe Asman’s visit, the regulator made a decision on the CarboClear Posterior Cervical Screw System and the hybrid system for posterior cervical spine fixation.
The indications include cervical spine tumors, traumatic fractures and dislocations, spinal instability, consequences of unsuccessful previous surgeries, degenerative diseases, and spinal infections.
The 510(k) procedure does not mean full preliminary approval under the most stringent PMA procedure. It means that the FDA recognized the device as sufficiently equivalent to already approved medical devices for sale.
CarboFix already had a history of working with Ukraine
The upcoming deliveries will not be the first appearance of CarboFix products on the Ukrainian market.
On December 14, 2012, the Ukrainian list of registered medical devices included:
No. 12234/2012 — implants for osteosynthesis CarboFix Orthopedics Ltd.;
No. 12235/2012 — tools for installing implants for osteosynthesis.
The Ukrainian organization associated with the registration was LLC “VOSTOK-MEDSERVICE”, registered in Donetsk (2012) at Shchorsa Street, 108. The registry noted that the validity of the certificates is unlimited.
The commercial customs database contains information about CarboFix deliveries to Ukraine in 2013–2014.
On April 24, 2013, deliveries of implants for osteosynthesis and surgical tools for their installation were processed.
On May 5, 2014, another batch of products was registered. The recipient was indicated as entrepreneur T. from Donetsk.
However, descriptions of some historical deliveries mention products made of stainless steel. Therefore, they cannot be automatically equated with modern radiolucent CFR-PEEK lines shown to Moshe Asman in Herzliya.
These data confirm another thing: CarboFix or related structures already had a registration and commercial history in Ukraine more than ten years ago.
The current process may mean the company’s return to the Ukrainian market, the creation of a new official distributor, or the restoration of operations after the loss of the previous structure in Donetsk.
Why the technology is especially important today
In the video, Moshe Asman specifically linked the appearance of CarboFix in Ukraine with helping wounded military personnel and civilians.
This direction indeed corresponds to the company’s specialization. CarboFix implants are designed for treating complex fractures of the femur, tibia, humerus, and other bones, non-unions, spinal injuries, and pathological fractures in oncological patients.
For people who have received severe injuries, the ability to constantly monitor the position of bones and the process of their fusion is of great importance. If the implant covers the damaged area less, it is easier for the doctor to assess the result of the operation, timely notice complications, and make decisions about further treatment.
But the real availability of the technology will depend not only on the appearance of the branch.
It is necessary to determine which modern systems have passed the Ukrainian conformity assessment, who will become the official importer, which hospitals will receive the necessary surgical tools, and whether Ukrainian doctors will be trained to work with specific systems.
The financial question is no less important: will the implants be purchased by the state, supplied as part of charitable programs, or paid for by the patients themselves.
At the moment, Moshe Reuven Asman has become the first public source to report not only on the creation of the CarboFix Orthopedics branch in Ukraine but also on the preparation of the first deliveries.
His statement from July 14, 2026 contains two main promises: modern Israeli implants should soon appear in Ukraine, and their potential recipients will be wounded military personnel and civilian patients.
Now, official information from CarboFix Orthopedics is expected: the name of the Ukrainian partner, the start date of deliveries, the list of available systems, and the medical institutions where the new implants will be used for the first time.